今年以来,港股创新药无疑是全市场最大的“黑马”。年内多只港股医药主题指数涨幅翻倍,以恒生港股通创新药指数(HSSCID.HI)为例,截至2025年8月6日,该指数年初以来涨幅高达107.68%。与此同时,全市场唯一一只跟踪该指数的ETF——恒生创新药ETF(159316)当前规模突破了10.8亿元。正是在板块高光之际,恒生指数公司开启了为恒生港股通创新药指数升级计划,在指数原有的基础上进一步剔除...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.